New Location is One of the 12 Total Dispensaries the Company Will Operate to Serve the Commonwealth’s Rapidly Growing Medical Cannabis Program
NEW YORK–(BUSINESS WIRE)–Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S. announced today that it has opened a third dispensary at 11190 West Broad Street in Glen Allen, Virginia, under the gLeaf brand.
“We are pleased to be able to serve the greater Richmond metropolitan area, especially on the heels of the recent addition of whole flower to our product offerings,” said Nicholas Vita, CEO of Columbia Care. “This dispensary opening marks the next step in our expansion in Virginia to help support the rapidly expanding medical program and its more than 33 thousand patients. We are thankful for the support from the Board of Pharmacy and local officials as we continue to grow and evolve.”
In the coming months, the Company will open two more locations in Carytown and Virginia Beach. Columbia Care and gLeaf are actively developing seven additional dispensaries for a total of 12. Columbia Care is also in the process of rebranding its Portsmouth location as Cannabist, bringing an elevated patient experience to the Hampton Roads area. The Company operates 147,765 square feet of cultivation and production space across Virginia, including its 82,000-square-foot indoor cultivation facility, the largest in the Commonwealth.
The new dispensary includes two drive-thru windows and 12 registers. It will carry gLeaf and Seed & Strain brands and expects to launch Triple Seven, Classix and other brands, pending regulatory approval. The store is open Monday through Saturday from 9:00am-8:00pm and Sunday from 9:00am-7:00pm.
For more information, please visit gleaf.com.
About Columbia Care
Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 18 U.S. jurisdictions and the EU. Columbia Care operates 130 facilities including 99 dispensaries and 31 cultivation and manufacturing facilities, including those under development. Columbia Care is one of the original providers of medical cannabis in the U.S. and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber and Platinum Label CBD. For more information on Columbia Care, please visit www.col-care.com.
Caution Concerning Forward-Looking Statements
This press release contains certain statements that constitute forward-looking information within the meaning of applicable securities laws and reflect the Company’s current expectations regarding future events. The Company has made assumptions with regard to its ability to execute on brand and product initiatives, which although considered reasonable by the Company, may prove to be incorrect and are subject to known and unknown risks and uncertainties that may cause actual results, performance or achievements of the Company to be materially different from those expressed or implied by any forward-looking information. Securityholders should review the risk factors discussed under “Risk Factors” in Columbia Care’s Annual Information Form dated March 31, 2021, filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com and described from time to time in documents filed by the Company with Canadian securities regulatory authorities.
Lee Ann Evans